A B S T R A C T When supernates from the established human breast cancer cell line MCF-7 were applied to fetal rat long bones that had been labeled with 45Ca and devitalized to remove endogenous bone cells, mineral was released from the bones. The release of bone mineral by supernates was associated with increased basal release of hydrolytic enzyme activity by the tumor cells. The basal release of lysosomal enzymes and collagenolytic activity by cells was approximately twice that of mouse 3T3 cells, which did not cause mineral release by the fetal rat bones. Release of hydrolytic enzymes and bone mineralreleasing activity was increased by colchicine and vinblastine, drugs that inhibit microtubule assembly, but not affected by lumicolchicine. Time-course experiments performed on MCF-7 cells with or without colchicine showed that release of cathepsin D and collagenolytic activity was associated more closely with release ofbone mineral and degradation ofbone matrix than was the release of N-acetylglucosaminidase. The release of previously incorporated [3H]proline from the bones exposed to MCF-7 cell cultures was more closely associated with release of collagenolytic activity by MCF-7 cells than with release ofcathepsin D or N-acetylglucosaminidase. These data suggest that breast cancer-mediated bone resorption in vitro is positively correlated with release of hydrolytic enzymes by the tumor cells, and release of these enzymes is enhanced by disassembly of microtubules.
INTRODUCTION
Osteolytic bone metastases are a frequent complication of breast cancer. Recently we found that breast cancer cells are capable of directly resorbing fetal rat long bones in vitro (1) . This effect of the breast cancer cells on bone occurred independent of endogeneous boneresorbing cells.
Osteoclast-mediated bone resorption has been correlated closely with release of hydrolytic enzymes (2) . When bone resorption is stimulated in vitro by parathyroid hormone or prostaglandin E2, there is increased release of lysosomal enzymes and when resorption is inhibited by calcitonin or cortisol, lysosomal enzyme release is diminished (3) . Colchicine, which inhibits microtubular assembly, is also a potent inhibitor of osteoclastic bone resorption. The purpose of this study was to examine the effects of drugs that inhibit microtubule assembly on the capacity ofcultured human breast cancer cells to cause bone mineral release and release of lysosomal enzymes and collagenolytic activity.
METHODS
Cell cultures. The MCF-7 cell line is an established epithelial human breast cancer cell line derived from the pleural effusion of a patient with advanced breast cancer (4) . The cells had been growing in a monolayer culture for over 5 yr. Our cells were obtained from E.G. and G. Mason
Research Institute, Rockville, Md. 3T3 nontransformed mouse fibroblasts were obtained from the American Type Culture Collection, Rockville, Md. Supemates ofcell cultures used in these experiments were taken from cultures that were near confluency. The MCF-7 and 3T3 cells were cultured in Dulbecco's modified Eagle's medium with 10% fetal calfserum and 10,Lg/ml insulin. These cultures were routinely split every 3 d. Cell culture media were centrifuged for 10 min at 1,000 g. The cell-free supemates were then adjusted to pH 7.4 with 1 M NaHCO3, and sterilized by passage through Millipore filters (pore size, 0.22 MLm; Millipore Corp., Bed- ford, Mass.).
Assay for bonte resorptioni. We have described a similar bioassay for bone resorption (1, 5) . Pregnant mice on the 16th d of gestation were injected subcutaneously with 0.04 mCi of 45Ca. The next day, the fetal radius and ulna were dissected free of the cartilagenous ends and surrounding soft tissue. Some pregnant mice were injected with 0.25 mCi of [3H]proline on the 16th, 18th, and 20th d of gestation. In these experiments the radius and ulna were obtained from the new-born animals. The bones were devitalized by wet exposuire overnight to ultraviolet light to kill endogenous bone cells and leave a calcified acellular bone matrix. We checked that endogenous bone cells were killed by adding parathyroid hormone to the bones and measuring release of 45Ca and incorporation of [3H]thymidine. There was no release of 45Ca or incorporation of [3H]thymidine by these bones. The bones were then washed in one change of fresh media to remove hydrolytic enzymes released by the dlead bone cells. The (levitalized bones were cultured with chemically defined medium developed by Biggers et al. (6) (Tables I and III) . The effects of colchicine (0.1 ,tM) on cell viability and on [3H]deoxyglucose uptake by the MCF-7 cells were tested after the cells had grown to confluency. There was no change in the percentage of cells excluding trypan blue after the addition of colchicine. Deoxyglucose uptake was also unaffected by colchicine.
[3H]deoxyglucose (0.1 ,Ci) was added to each of six separate cultures (three treated with colchicine, three without colchicine) and incubated for an additional 30 min. Radioactivity present in cell lysates was the same in cells treated with colchicine as cells without colchicine. In separate experiments, we found that after incubation of MCF-7 cells with 2-deoxyglucose, 75% of the total deoxyglucose was in the form of 2-deoxyglucose 6-phosphate (data not shown).
Supernates from MCF-7 cultures containing bone mineral-releasing activity and enzymatic activity were subjected to dialysis across Spectrapor membranes (assigned cut-off 3,500 daltons) and heat (Table III) . Dialyzed supernates retained their resorptive and enzymatic activity, whereas heating the supernates at 75°C for 10 min reduced enzymatic and resorptive activity significantly. Table IV shows the dose-response relationship of colchicine to the release of bone mineral and activity of the lysosomal enzyme N-acetylglucosaminidase by MCF-7 cells. There was a parallel inhibitory effect of colchicine on the release of bone mineral-releasing activity and the lysosomal enzyme. At 0.1 ,uM colchicine there was a clear increase in N-acetylglucosaminidase activity and bone mineral-releasing activity. There was no effect on either response by colchicine at 10 nM.
Cytochalasin B is an agent that inhibits microfilament function. To ascertain the effects ofalterations ofmicrofilament function on the release of bone resorbing activity and enzymes by the MCF-7 cells, we added cytochalasin B (2 uM) to MCF-7 cultures near confluency, harvested the media after 48 h and added the (Table V) . This suggests that inhibition ofmicrofilament function also increases production of enzymes and bone mineral-releasing activity by the MCF-7 cells. mineral release. This suggests that in this experimental system there is no limitation of available substrate for the enzymes, since decreased amounts of enzyme activity caused corresponding decreased release of bone mineral. If decreased substrate was a limiting factor greater dilutions would cause the same release of bone mineral. The effect of colchicine to cause enhanced enzyme activity in conditioned media from MCF-7 cells could represent increased release of enzymes or a decreased rate of endocytosis caused by colchicine. To assess the role of endocytosis, we examined the accumulation of horse radish peroxidase by MCF-7 cells and 3T3 cells treated with colchicine (0.1 ,uM) (Fig. 5) . In both instances there was a comparable inhibition of horse radish peroxidase accumulation in cells treated with colchicine. This suggests that the effect of colchicine on MCF-7 cells was different than that on 3T3 cells in that colchicine caused increased release of enzymes from the MCF-7 cells into the media. 5 The effect of colchicine on uptake of horse radish peroxidase into MCF-7 and 3T3 cells. Four cell cultures for each treatment group were incubated until they reached confluency. Horse radish peroxidase uptake was assessed according to the method of Steinman et Osteoclastic bone resorption is closely associated with hydrolytic enzyme production (2, 3, 13). It has not been possible to dissociate lysosomal enzyme release from bone resorption in tissue culture. In situations where osteoclastic bone resorption is stimulated by agents such as parathyroid hormone and prostaglandins E2, lysosomal enzyme production is also increased (2, 3, 13 release are similar, the increase in lysosomal enzyme release is proportionally greater and occurs earlier than the increase in 45Ca release. In addition, agents that inhibit bone resorption such as calcitonin and cortisol also inhibit lysosomal enzyme release.
The mechanism by which bone mineral release and matrix resorption is linked to enzyme production is not clearly understood. There are a number of different ways in which hydrolytic enzymes produced by bone-resorbing cells could initiate bone resorption. These enzymes could be responsible for degrading the noncollagenous portion of the bone matrix that comprises glycoproteins, proteoglycans, and lipid. Hydrolytic enzymes could initiate mineral release from bone by degrading those matrix components that normally prevent mineral release. Hydrolytic enzymes released from lysosomes might also assist cytoplasmic collagenase in the degradation of collagen directly or be responsible for the activation of collagenase from precursor forms.
Microtubular function is closely related to secretory events in many different types of cells. Although depolymerization of microtubules is usually associated with inhibition of secretion (14, 15) , it has been shown in cultured fibroblasts that disassembly ofmicrotubules leads to stimulation of release ofa number of lysosomal enzymes (16) . Others have found that membrane fusion leading to lysosomal discharge into incubation media occur independent of microtubules (17) . In osteoclasts, which are the major bone resorbing cells, depolymerization of microtubules by colchicine inhibits bone resorption and lysosomal enzyme release (3, 18) but simultaneously increases collagenase production (3).
Colchicine causes similar alterations in enzyme production by monocytes (19 (1) .
[3H]proline release and release of collagenolytic activity occurred at later time-points compared with lysosomal enzyme release and mineral release (Figs. 2 and 3) . This is consistent with the notion that collagenolytic activity is expressed after demineralization occurs, and the hypothesis that lysosomal enzymes are responsible for mineral release, and after removal of bone mineral collagenase degrades the collagenous bone matrix.
The present study provides further evidence that hydrolytic enzyme release is correlated closely with bone resorption. This correlation between hydrolytic enzymes and bone resorption occurs whether bone resorption is mediated by osteoclasts or by breast cancer cells. Clarification of the molecular mechanism ofbone resorption in breast cancer is important because osteolytic bone metastases, bone destruction, and hypercalcemia occur frequently in patients with ad-vanced breast carcinoma and are responsible for considerable morbidity and mortality in patients with this disease (20) .
